Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - SHORT-TERM DEBT
Short-term Debt AKBA - Akebia Therapeutics, Inc.
24 M
LAST VALUE
-51.54%
2 YEAR CAGR
9.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR